Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

Published:2010-02 Issue:2 Volume:11 Page:121-128
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Mitsudomi Tetsuya,Morita Satoshi,Yatabe Yasushi,Negoro Shunichi,Okamoto Isamu,Tsurutani Junji,Seto Takashi,Satouchi Miyako,Tada Hirohito,Hirashima Tomonori,Asami Kazuhiro,Katakami Nobuyuki,Takada Minoru,Yoshioka Hiroshige,Shibata Kazuhiko,Kudoh Shinzoh,Shimizu Eiji,Saito Hiroshi,Toyooka Shinichi,Nakagawa Kazuhiko,Fukuoka Masahiro

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

3. The differential efficacy of pemetrexed according to NSCLC histology: a review of two phase III studies;Scagliotti;Oncologist,2009

4. Lung cancer;Herbst;N Engl J Med,2008

5. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer;Fukuoka;J Clin Oncol,2003

Cited by 3565 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitinase 3-like-1 (CHI3L1) in the pathogenesis of epidermal growth factor receptor mutant non-small cell lung cancer;Translational Oncology;2024-11

2. Naringin alleviates gefitinib-induced hepatotoxicity through anti-oxidation, inhibition of apoptosis, and autophagy;IRAN J BASIC MED SCI;2024

3. EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR- mutated NSCLC: a network meta-analysis;2024-09-11

4. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine;Life;2024-09-10

5. Exploring the Use of Deep Learning Models in Predicting Genetic Mutations Associated with Non-Small Cell Lung Cancer: A Systematic Review (Preprint);2024-09-07